ECSP045180A - Proceso para la preparación de 7?-metilesteroides - Google Patents
Proceso para la preparación de 7?-metilesteroidesInfo
- Publication number
- ECSP045180A ECSP045180A EC2004005180A ECSP045180A ECSP045180A EC SP045180 A ECSP045180 A EC SP045180A EC 2004005180 A EC2004005180 A EC 2004005180A EC SP045180 A ECSP045180 A EC SP045180A EC SP045180 A ECSP045180 A EC SP045180A
- Authority
- EC
- Ecuador
- Prior art keywords
- formula
- preparation
- hydroxysteroid
- methyl
- grignard
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 230000001404 mediated effect Effects 0.000 abstract 2
- KVUXYQHEESDGIJ-UHFFFAOYSA-N 10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,16-diol Chemical compound C1CC2CC(O)CCC2(C)C2C1C1CC(O)CC1(C)CC2 KVUXYQHEESDGIJ-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 239000007818 Grignard reagent Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 150000004795 grignard reagents Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 125000004665 trialkylsilyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invención se refiere a un proceso para la preparación de 7a-metil hidroxiesteroides de la Fórmula I: (Fórmula I); en donde R1 es hidrógeno, metilo o C=CH; R2 es (CH2)nOH, en donde n es 0, 1 ó 2; por medio de una adición conjugada 1,6, mediada por cobre, de un reactivo de Grignard CH3MgX, siendo X un halógeno, al 3-cetoesteroide 4,6-insaturado de la fórmula II: (Fórmula II); en donde R1 y R2 tienen las definiciones proporcionadas anteriormente, que comprende la protección del grupo hidroxi del esteroide de la Fórmula II con un grupo trialquilsililo, seguida por el tratamiento del hidroxiesteroide protegido con el reactivo de Grignard. El proceso de la invención es útil para la producción de esteroides farmacológicamente interesantes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075230 | 2002-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045180A true ECSP045180A (es) | 2004-08-27 |
Family
ID=8185555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2004005180A ECSP045180A (es) | 2002-01-21 | 2004-07-06 | Proceso para la preparación de 7?-metilesteroides |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20050090476A1 (es) |
| EP (1) | EP1470151B1 (es) |
| JP (1) | JP5250174B2 (es) |
| KR (1) | KR100937179B1 (es) |
| CN (1) | CN100372864C (es) |
| AR (1) | AR038165A1 (es) |
| AT (1) | ATE453659T1 (es) |
| AU (1) | AU2003205604B8 (es) |
| BR (1) | BRPI0306736B8 (es) |
| CA (1) | CA2472379C (es) |
| DE (1) | DE60330749D1 (es) |
| EC (1) | ECSP045180A (es) |
| EG (1) | EG23417A (es) |
| ES (1) | ES2336439T3 (es) |
| HR (1) | HRP20040634B1 (es) |
| IL (2) | IL162770A0 (es) |
| IS (1) | IS2740B (es) |
| MX (1) | MXPA04007049A (es) |
| NO (1) | NO327095B1 (es) |
| NZ (1) | NZ533970A (es) |
| PE (1) | PE20030926A1 (es) |
| PL (1) | PL208163B1 (es) |
| RO (1) | RO122913B1 (es) |
| RS (1) | RS51490B (es) |
| RU (1) | RU2305105C2 (es) |
| TW (1) | TWI322813B (es) |
| WO (1) | WO2003059931A1 (es) |
| ZA (1) | ZA200405257B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10213371C1 (de) * | 2002-03-21 | 2003-12-24 | Schering Ag | Verfahren zur Herstellung von 7alpha-Methylsteroiden |
| GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| DE10352433B4 (de) | 2003-11-10 | 2012-10-11 | Nanotecmarin Gmbh | Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle |
| KR100716981B1 (ko) * | 2004-09-30 | 2007-05-10 | 삼성전자주식회사 | 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기 |
| US20130123541A1 (en) * | 2009-06-29 | 2013-05-16 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 3,3,5,5-tetramethylcyclohexanone |
| CN111944001A (zh) * | 2020-07-09 | 2020-11-17 | 浙江神洲药业有限公司 | 一种替勃龙的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341557A (en) * | 1961-06-05 | 1967-09-12 | Upjohn Co | 7-methyltestosterones |
| US3470216A (en) * | 1966-11-29 | 1969-09-30 | Du Pont | Selected 17,17-difluoro unsaturated androstanes |
| FR2054527B1 (es) * | 1969-07-28 | 1973-06-08 | Roussel Uclaf | |
| US3798213A (en) * | 1971-01-25 | 1974-03-19 | Merck & Co Inc | 7 alpha-methyl-20-spiroxane-3-ones and process |
| DE2558088C2 (de) * | 1975-12-19 | 1985-05-30 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten |
| JPS56145239A (en) * | 1980-04-11 | 1981-11-11 | Sumitomo Chem Co Ltd | Novel bicyclooctane derivative and its preparation |
| US4298559A (en) * | 1980-07-23 | 1981-11-03 | Dow Corning Corporation | High yield silicon carbide from alkylated or arylated pre-ceramic polymers |
| US6548491B2 (en) * | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| ES2204613T3 (es) * | 1999-04-06 | 2004-05-01 | Akzo Nobel N.V. | Androgenos 7-alfa alquilo oralmente activos. |
| TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| WO2001040255A2 (en) * | 1999-12-02 | 2001-06-07 | Akzo Nobel N.V. | 14,15-beta-methylene substituted androgens |
| US6784170B2 (en) * | 2000-02-11 | 2004-08-31 | Sri International | Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| BR0112791A (pt) * | 2000-07-28 | 2003-06-24 | Akzo Nobel Nv | Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica |
| US20040010138A1 (en) * | 2002-03-21 | 2004-01-15 | Schering Ag | Process for the production of 7alpha-methyl steroids |
| US7304157B2 (en) * | 2004-09-28 | 2007-12-04 | Bristol-Myers Squibb Company | Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
-
2003
- 2003-01-14 KR KR1020047010985A patent/KR100937179B1/ko not_active Expired - Lifetime
- 2003-01-14 MX MXPA04007049A patent/MXPA04007049A/es active IP Right Grant
- 2003-01-14 RS YUP-630/04A patent/RS51490B/sr unknown
- 2003-01-14 CA CA2472379A patent/CA2472379C/en not_active Expired - Lifetime
- 2003-01-14 NZ NZ533970A patent/NZ533970A/en not_active IP Right Cessation
- 2003-01-14 JP JP2003560033A patent/JP5250174B2/ja not_active Expired - Lifetime
- 2003-01-14 TW TW092100693A patent/TWI322813B/zh not_active IP Right Cessation
- 2003-01-14 RO ROA200400656A patent/RO122913B1/ro unknown
- 2003-01-14 BR BRPI0306736A patent/BRPI0306736B8/pt not_active IP Right Cessation
- 2003-01-14 HR HRP20040634AA patent/HRP20040634B1/hr not_active IP Right Cessation
- 2003-01-14 RU RU2004125580/04A patent/RU2305105C2/ru active
- 2003-01-14 IL IL16277003A patent/IL162770A0/xx unknown
- 2003-01-14 AT AT03702441T patent/ATE453659T1/de not_active IP Right Cessation
- 2003-01-14 CN CNB038024918A patent/CN100372864C/zh not_active Expired - Lifetime
- 2003-01-14 ES ES03702441T patent/ES2336439T3/es not_active Expired - Lifetime
- 2003-01-14 WO PCT/EP2003/000339 patent/WO2003059931A1/en not_active Ceased
- 2003-01-14 US US10/502,259 patent/US20050090476A1/en not_active Abandoned
- 2003-01-14 PL PL371583A patent/PL208163B1/pl unknown
- 2003-01-14 EP EP03702441A patent/EP1470151B1/en not_active Expired - Lifetime
- 2003-01-14 AU AU2003205604A patent/AU2003205604B8/en not_active Expired
- 2003-01-14 DE DE60330749T patent/DE60330749D1/de not_active Expired - Lifetime
- 2003-01-19 EG EG2003010051A patent/EG23417A/xx active
- 2003-01-20 AR ARP030100149A patent/AR038165A1/es unknown
- 2003-01-20 PE PE2003000062A patent/PE20030926A1/es active IP Right Grant
-
2004
- 2004-06-28 IS IS7339A patent/IS2740B/is unknown
- 2004-06-29 IL IL162770A patent/IL162770A/en active IP Right Grant
- 2004-07-01 ZA ZA2004/05257A patent/ZA200405257B/en unknown
- 2004-07-06 EC EC2004005180A patent/ECSP045180A/es unknown
- 2004-08-19 NO NO20043455A patent/NO327095B1/no not_active IP Right Cessation
-
2010
- 2010-04-22 US US12/765,629 patent/US20100204497A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900635A1 (ru) | Антагонисты прогестеронового рецептора | |
| BRPI1011015B8 (pt) | método para sintetizar pirfenidona | |
| BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
| DE60229530D1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
| MX2009014274A (es) | Espirociclos como inhibidores de 11-beta-hidroxil-esteroide-deshid rogenasa tipo 1. | |
| BRPI0615613A2 (pt) | diaminopirimidinas como moduladores de p2x3 e p3x2/3 | |
| ATE473746T1 (de) | Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens | |
| BRPI0712101B8 (pt) | ácido beta-fenil-alfa-hidróxi propanóico substituído, método de síntese e uso do mesmo | |
| ECSP045180A (es) | Proceso para la preparación de 7?-metilesteroides | |
| ATE517106T1 (de) | Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren | |
| BR112013005819A2 (pt) | mistura agrícola compreendendo uma fonte de sulfato e silicato de cálcio e processo de formação de formação da mesma | |
| BRPI0515062A (pt) | composições para tratamento de roupas para lavar com odor aprimorado | |
| BR0208265A (pt) | Redução estereosseletiva de acetofenona substituìda | |
| NO20085357L (no) | Fremgangsmate for fremstilling av renset hydrokinon og dannelse av det samme | |
| CY1111128T1 (el) | Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης | |
| PE20060590A1 (es) | COMPUESTOS ESTEROIDALES 15ß-SUSTITUIDOS CON ACTIVIDAD SELECTIVA DEL RECEPTOR DE ESTROGENOS | |
| DK1301526T3 (da) | Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre | |
| SE0400346D0 (sv) | Steroids for cancer treatment | |
| DK2099812T3 (da) | Fremgangsmåde til fremstilling af tagatose ved galactoseisomerisering med højt udbytte | |
| ATE354583T1 (de) | Verfahren zur herstellung c-7 substituierter 5- androstene | |
| BR0214643A (pt) | Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite | |
| HUP9903747A2 (hu) | Új eljárás mometazon-furoát előállítására | |
| ATE461934T1 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-car onsäure -lacton und schlüsselzwischenprodukte für dieses verfahren | |
| ATE468349T1 (de) | GROßTECHNISCHES VERFAHREN ZUR HERSTELLUNG VON 17- HYDROXY-6BETA, 7BETA, 15BETA,16BETA-BISMETHYLEN-3-OXO-17ALPHA-PREGN-4 EN-21-CARBONSÄURE-GAMMA- LACTON UND SCHLÜSSELZWISCHENPRODUKTE FÜR DIESES VERFAHREN | |
| NO20080894L (no) | Fremgangsmate for fremstilling av 3-okso-pregn-4-en-21, 17-karbolaktoner ved den metallfrie oksidasjonen av 17-(3-hydroksypropyl)-3,17-dihydroskyandrostaner |